Clinical Trials Logo

Clinical Trial Summary

This study is a multi-center, randomized, open-label, double-blind, positive-controlled phase II clinical study evaluating the efficacy and safety of different doses of SHR2285 tablets vs. enoxaparin for the prevention of postoperative venous thromboembolism in patients undergoing elective unilateral total knee arthroplasty.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05203705
Study type Interventional
Source Shanghai Hengrui Pharmaceutical Co., Ltd.
Contact Yun Jin
Phone +86 18818260161
Status Recruiting
Phase Phase 2
Start date March 8, 2022
Completion date May 13, 2023